Longeveron Announces 2025 Full Year Financial Results and Provides Business Update [Yahoo! Finance]
Janus Henderson Group plc Ordinary Shares (JHG)
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am
Check Earnings Report
US:NYSE Investor Relations:
snl.com/irw/corporateprofile/4147331
Company Research
Source: Yahoo! Finance
On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indication ELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacy Closed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused funds Company to host conference call and webcast today at 4:30 p.m. ET MIAMI, March 17, 2026 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial results for the year ended December 31, 2025 and provided a business
Show less
Read more
Impact Snapshot
Event Time:
JHG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JHG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JHG alerts
High impacting Janus Henderson Group plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JHG
News
- Ovid Therapeutics Announces Pricing of $60 Million Private Placement [Yahoo! Finance]Yahoo! Finance
- Janus Henderson Special Committee Confirms Receipt of Revised Unsolicited, Non-Binding Proposal from Victory CapitalBusiness Wire
- Northern Multi-Manager Global Real Estate Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- Evercore Updates Janus Henderson (JHG) Valuation After Reviewing February Flows [Yahoo! Finance]Yahoo! Finance
- Is Janus Henderson Group (JHG) Still Attractive After A 42.8% One Year Share Price Gain? [Yahoo! Finance]Yahoo! Finance
JHG
Earnings
- 1/30/26 - Beat
JHG
Sec Filings
- 3/18/26 - Form DEFA14A
- 3/17/26 - Form 425
- 3/17/26 - Form DEFA14A
- JHG's page on the SEC website